News
WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by ...
US consumption remains resilient, with retail sales rebounding in June despite widespread fears of tariff-driven inflation. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback